Status:
UNKNOWN
Interim PET/CT Guided Cycle Numbers of R-CHOP in DLBCL
Lead Sponsor:
Fudan University
Conditions:
Diffuse Large B-cell Lymphoma
Eligibility:
All Genders
18-80 years
Phase:
PHASE2
Brief Summary
The aim of this study is to optimize the number of cycles of R-CHOP in patients with diffuse large B-cell lymphoma based on the interim results of PET/CT.
Detailed Description
R-CHOP is the standard regimen for patients with diffuse large B-cell lymphoma (DLBCL). However, the standard number of cycles is uncertain. Recently, interim PET/CT was found to predict prognosis in ...
Eligibility Criteria
Inclusion
- Previously untreated diffuse large B-cell lymphoma
- Age range 18-80 years old
- Eastern Cooperative Oncology Group performance status 0-2
- Life expectancy of more than 3 months
- Adequate organ function
Exclusion
- Primary or secondary central nervous system involvement
- Previous serious cardiac disease
- History of other malignancies except cured basal cell carcinoma of skin and carcinoma in-situ of uterine cervix
- Pregnant or lactating women
- Serious uncontrolled diseases and intercurrent infection
Key Trial Info
Start Date :
February 1 2013
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 1 2017
Estimated Enrollment :
196 Patients enrolled
Trial Details
Trial ID
NCT01804127
Start Date
February 1 2013
End Date
December 1 2017
Last Update
March 5 2013
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Fudan University Cancer Hospital
Shanghai, Shanghai Municipality, China, 200032